NuView Life Sciences in the News
U.S. Spends Estimated $7.9 Billion on Unnecessary Biopsies
Categories
Recent Posts
- Delfi Diagnostics reels in $100M for blood-based cancer test
- Radiopharmaceuticals Are Showing Promise as the Next Generation of Cancer Treatment
- NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment
- Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential
- Park City company develops new ground breaking cancer treatment
Recommended For You
NuView Life Sciences in the News
Decreasing Breast Cancer False Positives with NV-VPAC1-PET Scan Technology
Karla Jo HelmsOctober 3, 2019
NuView Life Sciences in the News
Retired US Air Force Fighter Pilots Develop Prostate Cancer at Alarming Rates
Karla Jo HelmsSeptember 25, 2019
NuView Life Sciences in the News
Breakthrough Precision Medicine Technology for Non-Invasive Approach to Detecting Cancer
Karla Jo HelmsJuly 25, 2019